Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

EIGR Eiger BioPharmaceuticals Inc

1,725

0,00 (0,00%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Eiger BioPharmaceuticals (NASDAQ:EIGR)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Eiger BioPharmaceuticals Charts.

Eiger BioPharmaceuticals (NASDAQ:EIGR)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Eiger BioPharmaceuticals Charts.

News Eiger BioPharmaceuticals Inc

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
Montag 1 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 24 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan
Donnerstag 18 Januar 2024 (4 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Montag 8 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 4 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
Donnerstag 4 Januar 2024 (4 Monate vor) • PR Newswire (US)

Form DEF 14A - Other definitive proxy statements
Montag 11 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Montag 4 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Freitag 1 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Freitag 24 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Weitere Eiger BioPharmaceuticals Inc News-Artikel

BNP Paribas Issuance

Allianzim Us Large Cap B...

Landa APP 2 (GM)

Ameriprise Top Picks 202...

Link Linux (CE)

NLBNPIT20AI4 20240621 2.9

Bright Horizons Family S...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen